Dietary treatments outperform medications for IBS management

Dietary treatment is more effective than medications in irritable bowel syndrome (IBS). These are the findings of a study conducted at the University of Gothenburg.

Fatty liver disease was alleviated by Lilly’s ‘triple-G’ obesity drug in small study

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against

June 26, 2023

Study reveals novel neural coding mechanism for transferring perceptual information to memory

Our memories are rich in detail: we can vividly recall the color of our home, the layout of our kitchen, or the front of our

January 2, 2024

FDA accepts review of Viatris, Mapi’s NDA filing for GA Depot

GA Depot is intended for the treatment of relapsing forms of multiple sclerosis. Credit: Zerbor/Shutterstock.com. The US Food and Drug Administration (FDA) has accepted for

August 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.